"Unrelated Donors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Providers of tissues for transplant to non-related individuals.
| Descriptor ID |
D061349
|
| MeSH Number(s) |
M01.898.828
|
| Concept/Terms |
Unrelated Donors- Unrelated Donors
- Donor, Unrelated
- Unrelated Donor
- Donors, Unrelated
|
Below are MeSH descriptors whose meaning is more general than "Unrelated Donors".
Below are MeSH descriptors whose meaning is more specific than "Unrelated Donors".
This graph shows the total number of publications written about "Unrelated Donors" by people in this website by year, and whether "Unrelated Donors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 4 | 4 |
| 2014 | 4 | 2 | 6 |
| 2015 | 0 | 2 | 2 |
| 2016 | 3 | 1 | 4 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 4 | 7 |
| 2019 | 0 | 2 | 2 |
| 2020 | 2 | 7 | 9 |
| 2021 | 2 | 2 | 4 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Unrelated Donors" by people in Profiles.
-
Interplay between donor age and HLA-DP matching in 10/10?HLA-matched unrelated donor HCT. Blood Adv. 2024 10 22; 8(20):5438-5449.
-
Donor types and outcomes of transplantation in myelofibrosis: a?CIBMTR study. Blood Adv. 2024 08 27; 8(16):4281-4293.
-
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors. J Clin Oncol. 2024 Oct; 42(28):3277-3286.
-
Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations. Transplant Cell Ther. 2024 Sep; 30(9):909.e1-909.e11.
-
Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes. Blood Adv. 2024 05 14; 8(9):2235-2242.
-
Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis. Leukemia. 2024 Jun; 38(6):1432-1434.
-
Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort. Transplant Cell Ther. 2024 May; 30(5):544.e1-544.e8.
-
A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke. Stem Cells Transl Med. 2024 Feb 14; 13(2):125-136.
-
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. Am J Hematol. 2024 04; 99(4):785-788.
-
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2024 Mar; 59(3):373-379.